Web Analytics

3 Latest Announced Rounds

  • $17,000,000
    Unknown

    2 Investors

    Technology, Information and Internet
    Sep 5th, 2025
  • $40,000,000
    Unknown
    Retail Health and Personal Care Products
    Sep 5th, 2025
  • Undisclosed Amount
    Series A

    1 Investors

    Software Development
    Sep 5th, 2025
$697.45M Raised in 40 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Sionna Therapeutics

start up
United States - Boston, MA
  • 07/03/2024
  • Series C
  • $182,000,000

We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.


Related People

Michael CloonanFounder

Michael Cloonan United States - Needham, Massachusetts

N/A